| JYSB1800244 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2018-11-23 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2018-12-18 | view |
| JYSZ2200052 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | License Renew | 2022-10-10 | | Sanofi-Aventis Groupe;Sanofi Srl;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2500080 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Sanofi Srl;Sanofi Winthrop Industrie | | | view |
| JYSB2000012 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2020-02-10 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2020-04-08 | view |
| JYSB2300028 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2023-02-14 | | Sanofi-Aventis Groupe;Sanofi Srl | | | view |
| JYSB2000375 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | Sanofi SpA;Sanofi-Aventis Groupe | Filed | 2020-08-17 | view |
| JYSB2300124 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2023-07-19 | | Sanofi Srl;Sanofi Winthrop Industrie | | | view |
| JYSB1900073 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2019-04-15 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2019-06-03 | view |
| JYSB2200139 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2022-08-02 | | Sanofi-Aventis Groupe;Sanofi Srl | | | view |
| JYSB2300125 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2023-07-19 | | Sanofi Srl;Sanofi Winthrop Industrie | | | view |
| JYHB0800222 | 注射用拉布立海 | rasburicase | Lyophilized | Chemical Drugs | Supplementary Application | 2008-05-16 | | Glaxo Wellcome Production;Sanofi-Aventis | Approval Completed-Pending Certificated | | view |
| JYSB1900074 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2019-04-01 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2019-06-03 | view |
| JYSZ2200051 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | License Renew | 2022-10-10 | | Sanofi-Aventis Groupe;Sanofi Srl;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2000091 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2020-04-02 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2020-07-16 | view |
| JYHB0601067 | 注射用拉布立海 | rasburicase | Lyophilized | Chemical Drugs | Supplementary Application | 2006-12-20 | | Sanofi-Aventis;Sanofi Winthrop Industrie | Certificate Issued | 2007-06-11 | view |
| JYSF1800017 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2018-11-26 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2018-12-18 | view |
| JYSB2200140 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2022-08-02 | | Sanofi-Aventis Groupe;Sanofi Srl | | | view |
| JYSB2000092 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2020-03-26 | | Sanofi SpA;Sanofi-Aventis Groupe | Certificate Issued | 2020-07-16 | view |
| JYSB2300027 | 注射用拉布立海 | rasburicase | Lyophilized | Biological Products | Supplementary Application | 2023-02-14 | | Sanofi-Aventis Groupe;Sanofi Srl | | | view |
| JYHB1301024 | 注射用拉布立海 | rasburicase | Lyophilized | Chemical Drugs | Supplementary Application | 2013-09-26 | Sanofi-aventis groupe | Sanofi-Aventis Groupe;Sanofi-Aventis SpA | Approval Completed-Pending Certificated | 2014-09-25 | view |
